A new test for diagnosing Hepatitis C in outpatient clinics
Point-of-care Nucleic Acid Amplification Test for pangenomic Hepatitis C diagnosis in outpatient clinics
This study is working on a quick and easy test for Hepatitis C that you can take without needing a blood draw or fancy lab equipment, so more people can get tested and treated, especially those who might not even know they have the virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11131266 on NIH RePORTER |
What this research studies
This research focuses on developing a point-of-care nucleic acid amplification test (NAAT) for diagnosing Hepatitis C virus (HCV) infections in outpatient settings. The goal is to create a simple, rapid test that does not require blood draws or complex laboratory equipment, making it easier for patients to get tested and receive timely treatment. By improving access to accurate HCV testing, the research aims to identify more cases of HCV, especially among those who are asymptomatic and unaware of their infection. This approach could significantly enhance patient follow-up and linkage to effective antiviral treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who may be at risk for Hepatitis C infection or those who have not been previously diagnosed.
Not a fit: Patients who have already been diagnosed and are receiving treatment for Hepatitis C may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accessible diagnosis of Hepatitis C, ultimately improving treatment rates and health outcomes for patients.
How similar studies have performed: Other research has shown success with similar point-of-care testing approaches, indicating a promising avenue for improving HCV diagnosis.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Posner, Jonathan D — University of Washington
- Study coordinator: Posner, Jonathan D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.